Trial · NCT05788289
Adverse events20
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 20
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Participants With Mantle Cell Lymphoma | 1 | 4 | |
| other | Fatigue | General disorders | Participants With Mantle Cell Lymphoma | 1 | 4 | |
| other | Infusion related reaction | Injury, poisoning and procedural complications | Participants With Mantle Cell Lymphoma | 1 | 4 | |
| other | Nausea | Gastrointestinal disorders | Participants With Mantle Cell Lymphoma | 1 | 4 | |
| other | Creatinine increased | Investigations | Participants With Mantle Cell Lymphoma | 1 | 4 | |
| other | Platelet count decreased | Investigations | Participants With Mantle Cell Lymphoma | 1 | 4 | |
| other | Dysphagia | Gastrointestinal disorders | Participants With Mantle Cell Lymphoma | 1 | 4 | |
| other | Edema face | General disorders | Participants With Mantle Cell Lymphoma | 1 | 4 | |
| other | Generalized muscle weakness | Musculoskeletal and connective tissue disorders | Participants With Mantle Cell Lymphoma | 1 | 4 | |
| other | Rash maculo-papular | Skin and subcutaneous tissue disorders | Participants With Mantle Cell Lymphoma | 1 | 4 | |
| serious | Infusion related reaction | Injury, poisoning and procedural complications | Participants With Mantle Cell Lymphoma | 1 | 4 | |
| serious | Edema Face | General disorders | Participants With Mantle Cell Lymphoma | 1 | 4 | |
| serious | Delirium | Psychiatric disorders | Participants With Mantle Cell Lymphoma | 1 | 4 | |
| serious | Lymphocyte count increased | Investigations | Participants With Mantle Cell Lymphoma | 1 | 4 | |
| serious | Abdominal pain | Gastrointestinal disorders | Participants With Mantle Cell Lymphoma | 1 | 4 | |
| serious | Vomiting | Gastrointestinal disorders | Participants With Mantle Cell Lymphoma | 1 | 4 | |
| serious | Cough | Respiratory, thoracic and mediastinal disorders | Participants With Mantle Cell Lymphoma | 1 | 4 | |
| serious | Lethargy | Nervous system disorders | Participants With Mantle Cell Lymphoma | 1 | 4 | |
| serious | Skin infection | Infections and infestations | Participants With Mantle Cell Lymphoma | 1 | 4 | |
| serious | Death NOS | General disorders | Participants With Mantle Cell Lymphoma | 4 | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05788289/events